|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Stock appreciation rights compensation | |||||
| Issuance of restricted common stock | |||||
| Realized (gain) loss on short-term investments | |||||
| Unrealized gain on short-term investments | |||||
| Change in operating assets and liabilities: | |||||
| Other receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of short-term investments | |||||
| Sale of short-term investments | |||||
| Net cash (used in)/provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock, net | |||||
| Payment of ATM fees | |||||
| Proceeds from options exercised for common stock | |||||
| Net cash provided by/(used in) financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
Loading...